PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCY16
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $38,426
Award facts
- Contract value 100% obligated
- $38,426.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award (Contract No. 4570718921) valued at $38,426.40 from the Defense Logistics Agency's Medical Supply Chain on February 4, 2026. This firm fixed-price, non-set-aside contract was awarded on a competitive basis and is scheduled for completion by February 5, 2026. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle that runs through December 2026 and serves as the primary procurement mechanism for pharmaceutical and medical supply support to military healthcare systems worldwide.
AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive portfolio of medications and medical commodities including brand-name and generic drugs, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. The parent company, Cencora, Inc., holds an even larger indefinite delivery contract with DLA valued at up to $999.99 billion extending through December 2031, positioning the organization as a critical vendor for federal military and veteran healthcare procurement. The DLA Medical Supply Chain has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, demonstrating continued reliance on AmerisourceBergen's capabilities to support government healthcare operations globally.
Quick answers
Who was awarded contract SPE2D826FCY16?
SPE2D826FCY16 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on February 4, 2026.
How much is contract SPE2D826FCY16 worth?
The government has obligated $38,426 on SPE2D826FCY16.
Is contract SPE2D826FCY16 an order under another contract?
Yes. SPE2D826FCY16 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D826FCY16 competed?
The extent of competition for SPE2D826FCY16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award